Therapeutic interventions in gastrointestinal disease based on an understanding of inflammatory mediators
Authors:
- 1 July 1992
- journal article
- review article
- Published by Springer Nature in Inflammation Research
- Vol. 36 (3) , C22-C26
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.Gut, 1991
- Plasma and tissue interleukin-2 receptor levels in inflammatory bowel diseaseClinical and Experimental Immunology, 1990
- PATHOGENESIS OF CROHN'S DISEASE: MULTIFOCAL GASTROINTESTINAL INFARCTIONThe Lancet, 1989
- Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.Journal of Clinical Investigation, 1989
- Chemotactic activity in inflammatory bowel diseaseDigestive Diseases and Sciences, 1987
- Modulation of human colonic arachidonic acid metabolism by sulfasalazineDigestive Diseases and Sciences, 1985
- Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa.Gut, 1983
- Imbalance of prostacyclin and thromboxane synthesis in Crohn's disease.Gut, 1983
- Inhibition of prostaglandin synthetase in human rectal mucosa.Gut, 1983
- Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay.Gut, 1981